Company Data
Aprea Therapeutics Inc.
Ticker
APRE
Current Price
$0.6 1.16%
Market Cap
$7.6M
Price Target
Refer to Report
Volume
136.9K
52wk Range
$0.548 - $1.69
Overview
Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing cancer therapeutics that reactivate mutant p53 tumor suppressor protein. Its product candidate, APR-246, is a small molecule p53 reactivator that is in late-stage clinical development for hematologic malignancies, including myelodysplastic syndromes (MDS), and acute myeloid leukemia (AML).